According to the global brokerage firm, the flat BSE 200 corporate earnings amidst strong real GDP growth, should not be taken as evidence against a pick-up in growth, but as a function of "measurement and composition" differences.
"Looking forward, we expect the macroeconomic recovery to continue, earnings to grow at a faster pace and Indian equities to outperform the rest of the region," Goldman Sachs said in the research note.
After five consecutive quarters of decline, profits for the past two quarters for MSCI India have grown 9 per cent and 7 per cent year-on-year respectively and are tracking roughly in line with 10 per cent full-year forecast.
"Consequently, our strategists remain overweight on Indian equities as cyclical upturn and earnings recovery is on track. They expect MSCI India to deliver 12 per cent EPS CAGR for 2016/17, highest among its regional peers," the report added.
Also Read
Moreover, the equity market has different sector weightings than the economy as a whole. While, agriculture is a significant part of India's economy it is essentially absent from the equity market.
Further, commodity prices are more important to equity market than to the economy as a whole and another major difference is that while manufacturing companies (including pharmaceuticals and chemicals industry) constitute a relatively larger share of the equity market, services are somewhat 'under-represented'.
In order to benefit from the swings in the underlying economic growth, investors should buy consumption beneficiaries (those stocks that are likely to benefit from improving agriculture growth and the civil service wage hike) and government capex beneficiaries (that are poised to benefit from government spending on public infrastructure projects), the report said.
Disclaimer: No Business Standard Journalist was involved in creation of this content